COVAXIN vaccine

Photo: ABP News

No Paracetamol Needed For Children After COVAXIN Dose: Bharat Biotech

The Hyderabad-based Bharat Biotech advised not to give any pain killers, paracetamol or any other drug to children, who took COVID-19 vaccine doses. "No paracetamol or pain killers are recommended after being vaccinated by COVAXIN," said Bharat Biotech in a tweet. Reportedly, mild symptoms, which usually last for 1-2 days, can be resolved without any medication. However, the company also recommended consulting with a physician for medication… read-more

Fri, 07 Jan 2022 - 05:04 PM / by Varsha Joshi

Tags: Covid-19, Paracetamol Tablet, children, Covaxin, Bharat biotech

Courtesy: The Print

Covaxin

Photo: Business Standard

DCGI Gives Nod To Bharat Biotech For Administering Covaxin To Kids

Hyderabad-based Bharat Biotech was granted emergency approval to administer the COVID-19 vaccine to kids between the age of 12 to 18 years by the Drug Controller General of India (DCGI), on December 25. Reportedly, the company has further started the regulatory process to make it available on CoWin platform. Biotech's vaccine has become the second vaccine to receive approval after Zydus Cadila's three-dose needle-free vaccine ZyCoV-D in India… read-more

Sun, 26 Dec 2021 - 09:02 AM / by Brijesh Goswami

Tags: Covaxin, Bharat biotech, DCGI, approval, kids

Courtesy: Money Control

Covaxin

Photo: Bharat Biotech Website

Covaxin To Be Exported Internationally In December 2021

Hyderabad based manufacturer of Covaxin (Covid-19 vaccine) on November 29, announced to commence international export of the vaccine doses. The execution of the exportation was completed in November, and will now be shipped in December. The company thanked the Central Government (for export) and said, the vaccines will be exported to countries, which approved the emergency use of Covaxin. So far, only SII was allowed to export the Covid-19… read-more

Mon, 29 Nov 2021 - 06:15 PM / by Varsha Joshi

Tags: Covaxin, Hyderabad, Global Export, Indian government, Vaccine Export

Courtesy: The Siasat Daily

Covaxin

Photo: India Blooms

Only Covaxin Gives 65.2% Efficacy Against COVID-19 Delta Variant: Lancet

The recent study by the Lancet peer-review said Covaxin surpassed all the vaccines in terms of efficacy against the Delta variant by providing 65.2% efficacy, said vaccine maker Bharat Biotech on November 12. The Lancet also said that it provides 77.8% efficiency against symptomatic patients. It provides ''70.8% protection against all variants of SARS-CoV-2 virus,'' said the maker. However, 12% of people experienced common side effects of the… read-more

Fri, 12 Nov 2021 - 03:42 PM / by Brijesh Goswami

Tags: Covid-19, Covaxin, Lancet, Bharat Bitotech, Study

Courtesy: Time Now News

Covaxin

Photo: Hindustan Times

Covaxin Maker Seeks Approval In US For Children Under 18 Years

Bharat Biotech's partner Ocugen on November 6, asked the US Food and Drug Administration (FDA) for the emergency use authorisation of Covaxin for children under 18 years. Earlier the vaccine was granted approval by the World Health Organisation (WHO) for its Emergency Use Listing (EUL). "We are pleased to announce our EUA filing to the US-FDA through our partners-Ocugen,"… read-more

Sat, 06 Nov 2021 - 06:00 PM / by SAM RAHUL RAJASHEKHAR

Tags: covid 19, Coronavirus, Covaxin, Bharat biotech, FDA

Courtesy: ANI

Covaxin.

Photo: Rediffmail

WHO Gives Approval To Bharat Bitoech's Covaxin For Emergency Use

World Health Organisation's (WHO), Technical Advisory Group (TAG) reportedly gave Emergency Use Listing (EUL) status to Bharat Biotech's Covaxin on November 3. Covaxin has been found 77.8% effective against symptomatic COVID-19 and 65% against the new Delta Variant. The decision came after the WHO had sought more clarifications from the company on October 26. Covaxin has become the second Indian vaccine to get the status after Covishield. … read-more

Wed, 03 Nov 2021 - 06:15 PM / by Brijesh Goswami

Tags: WHO, emergency use, Bharat biotech, Covaxin, approval

Covaxin

Photo: The Financial Express

Bharat Biotech's Covaxin Gets Guyana's Approval, Awaits WHO's Recognition

Guyana on November 2 announced that it has decided to add Bharat Biotech's Covaxin to its recognised list of COVID-19 vaccines. Notably, Australia also announced to recognise Covaxin as COVID-19 vaccine in its country on November 1. However, the company is still waiting for World Health Organisation's approval for Covaxin which will help it to get recognition from all the countries in the world. 

Tue, 02 Nov 2021 - 05:55 PM / by Brijesh Goswami

Tags: Guyana, Covaxin, Bharat Bitotech, Covid-19, India

Courtesy: ANI

Australian and Indian PM in a Meeting.

Photo: Business Standard

Australia Annonuces To Recongnise Covaxin As COVID-19 Vaccine

In a major boost to Bharat Biotech, Australia on November 1 announced that it's added the company's Covaxin to the list of approved COVID-19 vaccines in the country. The decision was announced by Australia's High Commissioner to India Barry O'Farrell on Twitter. Reportedly, the decision will help many who've received Covaxin and wants to travel to Australia. The country already recognises the Covishield Vaccine of AstraZeneca India. 

Mon, 01 Nov 2021 - 03:00 PM / by Brijesh Goswami

Tags: Australia, Covaxin, Covid-19, vaccine, Bharat biotech

Courtesy: ANI

Covaxin still image

Twitter

Oman Adds 'COVAXIN' To Its Approved List Of COVID-19 Vaccines

Oman On October 27 has decided to include "COVAXIN" on their country's approved list of Covid-19 vaccines. The Indian Embassy in Muscat said, "All passengers from India who have received two doses of Covaxin at least 14 days before estimated arrival date, will now be able to travel to Oman without the requirement of quarantine." However, COVID-19 protocols, such as the pre-arrival RT-PCR test will be mandatory.

Wed, 27 Oct 2021 - 08:40 PM / by SAM RAHUL RAJASHEKHAR

Tags: Covid-19, Covaxin, Oman, Indian Embassy, Travel

Courtesy: ANI

COVAXIN

Photo: Business Standard

WHO Requests Explanations On Covaxin; To Reconvene On November 3 For Final Review

WHO announced on October 26, that Technical-Advisory-Group (TAG) for Emergency-Use-Listing (EUL) has made the decision that added clarifications from Bharat-Biotech are required before a final EUL risk-benefit assessment for global use of Covaxin can be conducted. WHO stated that TAG “expects to receive these clarifications by the end of this week, and aims to reconvene on November 3”. Covaxin's acceptance by foreign countries is contingent… read-more

Wed, 27 Oct 2021 - 12:36 PM / by Vidhi Jhunjhunwala

Tags: Covaxin, Bharat biotech, WHO, Emergency Use Authorization

Courtesy: The Indian Express